NYSA Fund
Data updated: 2020-11-24
C000013264 — NYSA Fund. Developed ex-US Blend / Core Equity · $1.67M AUM · 5.16% expense ratio. Holdings, fees, performance and SEC filings.
C000013264 Fund Overview
NYSA Fund is a US mutual fund managed by Nysa Series Trust, categorised as Developed ex-US Blend / Core Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Nysa Series Trust
- Category: Developed ex-US Blend / Core Equity
- Assets under management: $1.67M
- SEC CIK: 0001027657
- SEC series ID: S000004908
- Share class ID: C000013264
C000013264 Investment Objective and Strategy
NYSA Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Nysa Series Trust.
Investment objective
The Funds investment objective is to provide long-term capital growth.
Principal investment strategy
Investments in Equity Securities The Fund seeks to achieve its investment objective by investing primarily in the common stocks of publicly-traded companies. Fund shareholders will be provided with at least 60 days prior notice of any change in this policy. The Adviser uses fundamental analysis to identify securities with potential for capital appreciation. The Adviser focuses on companies projecting above average earnings and revenue growth, as compared to market averages (as represented by the S&P 500 Index). Also, the Fund invests in companies the Adviser believes to be undervalued by the current market. The Fund buys shares in companies of all sizes. Small and medium sized companies may occasionally make up a significant portion of the Funds portfolio. However, there is no assurance that these factors and the other characteristics that the Adviser believes favor these companies will continue in the future.
The Fund can buy stocks of companies without regard to market capitalization. Investments may be made in micro-cap companies (having a market capitalization of between $50 million and $300 million), small cap companies (having a market capitalization of between $300 million and $2 billion), mid cap companies (having a market capitalization between $2 billion and $10 billion), large cap companies (having a market capitalization between $10 billion and $200 billion) and mega cap companies (having a market capitalization of $200 billion and greater). While newer, small companies may offer greater opportunities for capital appreciation, they also involve a substantially greater risk of loss and price fluctuation. The Fund is not a diversified fund, and, as such, may invest more than 5% of its total assets in the securities of one or more issuers.
As a result, a relatively high percentage of the Funds assets may be invested in the securities of a limited number of issuers or a single issuer and, from time to time, in a limited number of industries. Subject to the fundamental investment policies and restrictions of the Fund, many of which are described in the Statement of Additional Information dated September 29, 2017, the Fund may emphasize investments in various market sectors from time to time. The Funds ability to invest up to 25% of its portfolio assets in a single industry or group of industries may offer greater opportunities for capital appreciation, but may also subject the Fund to a greater risk of loss and price fluctuation. The Fund is not a sector fund, and, as such may change its investment emphasis. As of the date of this prospectus, the Funds portfolio reflects an investment focus in the health care and the pharmaceutical industries.
As of June 30, 2018, 56.39% of the Funds (total) assets were invested in the pharmaceutical industry and 19.54% of the Fund (total) assets were invested in the surgical and medical instrument industry. Because of this current investment focus an investment in the Fund should be considered as a complementary investment to an already diverse investment program. The Fund is not restricted with regard to portfolio turnover and will make changes in its investment portfolio from time to time as business and economic conditions and market prices may dictate and its investment policies may require. The Fund may engage in active and frequent trading of portfolio securities, especially during periods of market volatility. The transaction costs attendant to this portfolio strategy will result in increased costs to the Fund.
A high rate of portfolio turnover in any year will increase brokerage commissions paid by the Fund, thus reducing the Funds total return, and could result in high amounts of realized investment gain subject to the payment of taxes by shareholders when Fund shares are held in taxable accounts. Investments in Debt Securities In seeking its investment objective of capital appreciation, the Fund invests mainly in equity securities. However, from time to time, the Fund may also invest in bonds, debentures and other debt securities and instruments, some of which may be convertible into equity securities. A debt security is a security that represents the obligation of an issuer to repay money borrowed. The terms of a debt security specify the principal amount of the indebtedness, the interest rate or discount, and the times at which payments of principal and/or interest are due.
Debt securities may include domestic and foreign corporate debt obligations; domestic and foreign government debt obligations, including U.S. government securities; mortgage related securities; asset backed securities and other debt obligations. The Fund may invest up to 15% of its net assets in a variety of debt securities. These securities may be taxable or tax-exempt, and may be rated or unrated. The tax-exempt securities in which the Fund may invest include obligations of the governments of U.S. territories, commonwealths and possessions such as Puerto Rico, or of their agencies, instrumentalities and authorities, if the interest on such securities is not subject to New York and federal income tax. Subject to the limitation on investments in illiquid securities described below, the Fund may invest up to 10% of its net assets in debt securities that are rated below investment grade, unrated and/or illiquid.
These investments may include high risk investments such as junk bonds. The 10% limitation is applied at the time of purchase and the Fund may continue to hold a security whose credit rating has been lowered, or in the case of an unrated security, after the Funds adviser has changed its assessment of the securitys credit quality. As a result credit rating downgrades or other market fluctuations may cause the Funds holdings of below-investment-grade securities to exceed this 10% restriction for some period of time. If the Fund has more than 10% of its net assets invested in below-investment-grade securities, the Adviser will not purchase additional below-investment-grade securities until the level of holdings in those securities no longer exceeds the limitation.
C000013264 Costs and Fees
C000013264 costs about $516 per $10,000 invested per year in fund expenses.
- Net expense ratio: 5.16%
- Gross expense ratio: 6.16%
- Portfolio turnover: 46%
- Brokerage commissions: 0.00 bps of average net assets (SEC N-CEN)
C000013264 Cashflows
Over the 12 months to 2020-08, NYSA Fund had net outflows of $30.36K, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2020-08 | −$7.21K |
| 2020-07 | −$3.14K |
| 2020-06 | −$5.36K |
| 2020-05 | −$4.08K |
| 2020-04 | −$825 |
| 2020-03 | −$641 |
C000013264 Debt Constituents
No individual debt constituents are reported in NYSA Fund's latest SEC N-PORT filing.
C000013264 Prospectus and SEC Filings
Official NYSA Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other Developed ex-US Blend / Core Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.